Physician profile
Brian Elliott
NPI 1790990752
$289.50
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.79 · 2020: $50.50 · 2021: $171 · 2022: $40.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $140.21 | 2021-2022 | |
| Angiodynamics, INC. | $34.90 | 2020 | |
| Medtronic, INC. | $33.35 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.91 | 2022 | |
| Boston Scientific Corporation | $17.74 | 2021 | |
| Hologic Sales and Service, LLC | $15.60 | 2020 | |
| Merck Sharp & Dohme LLC | $15.38 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.